List of publications

All the publications of the C3M teams.

Export in CSV
The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitntriors.

Authors Muller C, Lacroix-Malgras V, Kluza J, Laine W, Güler Y, Bost F, Boisbrun M, Mazerbourg S, Flament S

Cancer cell international Apr 2024

HSPA8 chaperone complex drives chaperone-mediated autophagy regulation in acute promyelocytic leukemia cell differentiation.

Authors Rafiq S, Mungure I, Banz Y, Niklaus NJ, Kaufmann T, Müller S, Jacquel A, Robert G, Auberger P, Torbett BE, Muller S, Tschan MP, Humbert M

Pharmacology Apr 2024

Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.

Authors Meierjohann S, Bertolotto C

Signal transduction and targeted therapy Apr 2024

[PROTAC technology: a promising approach in oncology].

Authors Azuaga Moreso M, Bertrand C, Duffrene J, Dumont M, Lecouffe A, Muller C, Arrighi N, Onesto C

Medecine sciences : M/S Mar 2024

[Trained immunity : emerging strategies against antibiotic resistance].

Authors Badin L, Franc C, Gilbert P, Magdeleine JJ, Martin L, Vernaz R, Arrighi N, Garcia-Sanchez JA

Medecine sciences : M/S Mar 2024

[When ubiquitination intertwines with cutaneous melanoma: a mechanism to explore].

Authors Arrighi N, Breda L, Kerdilès T, Meyer C, Prugneau L, Rabatel O, Wagner G, Krossa I, Pisibon C

Medecine sciences : M/S Mar 2024

Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial.

Authors Estran S, Loschi M, Benachour S, Soldati A, Chiche E, Sammut R, Robert G, Jacquel A, Chibois J, Schneider S, Cluzeau T

Bone marrow transplantation Mar 2024

Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

Authors Montemagno C, Jacquel A, Pandiani C, Rastoin O, Dawaliby R, Schmitt T, Bourgoin M, Palenzuela H, Rossi AL, Ambrosetti D, Durivault J, Luciano F, Borchiellini D, Le Du J, Gonçalves LCP, Auberger P, Benhida R, Kinget L, Beuselinck B, Ronco C, Pagès G, Dufies M

Journal of experimental & clinical cancer research : CR Mar 2024

Mechanisms of melanoma aggressiveness with age.

Authors Bertolotto C

Nature aging Mar 2024

Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.

Authors Krug A, Tosolini M, Madji Hounoum B, Fournié JJ, Geiger R, Pecoraro M, Emond P, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E

Journal of experimental & clinical cancer research : CR Feb 2024